DK2293687T3 - Funktionel fodersammensætning - Google Patents
Funktionel fodersammensætning Download PDFInfo
- Publication number
- DK2293687T3 DK2293687T3 DK09735856.8T DK09735856T DK2293687T3 DK 2293687 T3 DK2293687 T3 DK 2293687T3 DK 09735856 T DK09735856 T DK 09735856T DK 2293687 T3 DK2293687 T3 DK 2293687T3
- Authority
- DK
- Denmark
- Prior art keywords
- fish
- peptidoglycan
- infection
- composition
- nucleotides
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 40
- 235000019688 fish Nutrition 0.000 claims description 86
- 241000251468 Actinopterygii Species 0.000 claims description 71
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 claims description 62
- 108010013639 Peptidoglycan Proteins 0.000 claims description 62
- 239000002773 nucleotide Substances 0.000 claims description 54
- 125000003729 nucleotide group Chemical group 0.000 claims description 54
- 208000015181 infectious disease Diseases 0.000 claims description 34
- 230000004083 survival effect Effects 0.000 claims description 27
- 238000011282 treatment Methods 0.000 claims description 27
- 241000277263 Salmo Species 0.000 claims description 13
- 241000277331 Salmonidae Species 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 10
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 208000035473 Communicable disease Diseases 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 208000024891 symptom Diseases 0.000 claims description 5
- 241000589601 Francisella Species 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 241001600139 Moritella viscosa Species 0.000 claims description 3
- 201000002481 Myositis Diseases 0.000 claims description 3
- 241000711648 Norwegian salmonid alphavirus Species 0.000 claims description 3
- 208000035415 Reinfection Diseases 0.000 claims description 3
- 206010061372 Streptococcal infection Diseases 0.000 claims description 3
- 206010047400 Vibrio infections Diseases 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 208000007502 anemia Diseases 0.000 claims description 3
- 230000002458 infectious effect Effects 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 210000002027 skeletal muscle Anatomy 0.000 claims description 3
- 210000002816 gill Anatomy 0.000 claims 2
- 208000016222 Pancreatic disease Diseases 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 description 47
- 230000037213 diet Effects 0.000 description 43
- 238000002474 experimental method Methods 0.000 description 24
- 230000000694 effects Effects 0.000 description 22
- 241000192126 Piscirickettsia salmonis Species 0.000 description 15
- 244000144974 aquaculture Species 0.000 description 14
- 238000009360 aquaculture Methods 0.000 description 13
- 241000269979 Paralichthys olivaceus Species 0.000 description 11
- 241000277289 Salmo salar Species 0.000 description 10
- 235000020940 control diet Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 231100000636 lethal dose Toxicity 0.000 description 8
- 239000013535 sea water Substances 0.000 description 6
- 208000035240 Disease Resistance Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000238552 Penaeus monodon Species 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229960001438 immunostimulant agent Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 235000021195 test diet Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 230000007124 immune defense Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 230000015788 innate immune response Effects 0.000 description 4
- 241000277275 Oncorhynchus mykiss Species 0.000 description 3
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000000366 juvenile effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 230000006058 immune tolerance Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000001325 log-rank test Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229960000321 oxolinic acid Drugs 0.000 description 2
- 208000024691 pancreas disease Diseases 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 238000010824 Kaplan-Meier survival analysis Methods 0.000 description 1
- 241000277338 Oncorhynchus kisutch Species 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 241000927735 Penaeus Species 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000544286 Vibrio anguillarum Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000028454 lice infestation Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000005257 nucleotidylation Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- -1 phosphor ester Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012794 pre-harvesting Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Birds (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (16)
1. Fiskefodersammensætning omfattende konventionelle foderingredienser, kendetegnet ved, at fodersammensætningen omfatter peptidoglykan og nukleoti-der, hvori peptidoglykan er i området 0,001-0,01 vægt-%, mere foretrukket 0,001-0,005 vægt-% og mest foretrukket 0,005 vægt-%.
2. Fodersammensætning ifølge krav 1, kendetegnet ved, at nukleotiderne er i området 0,05-1 vægt-%, fortrinsvis 0,1-0,5 vægt-% og mest foretrukket 0,2 vægt-%.
3. Fodersammensætning ifølge krav 1, kendetegnet ved, at vægtforholdet af nukleotider til peptidoglykan er mere end 4, mere foretrukket mere end 20, og mere foretrukket mere end 40, og mængden af peptidoglykan er i område 0,001-0,01% af fodersammensætningens vægt.
4. Fodersammensætning ifølge krav 1, hvori mængden af nukleotider er omkring 0,2% og mængden af peptidoglykan er omkring 0,005% af den samlede vægt af fodersammensætningen.
5. Fodersammensætning omfattende konventionelle foderingredienser, nukleotider og peptidoglykan til anvendelse ved forebyggelse og/eller behandling af infektionssygdomme i fisk og/eller til reduktion af symptomer på en infektionssygdom, hvori peptidoglykan er i området 0,001-0,01%
6. Fodersammensætning ifølge krav 5, hvori peptidoglykan er i området 0,001-0,005 vægt-% og fortrinsvis 0,005 vægt-%.
7. Fodersammensætning ifølge krav 5, hvori sammensætningen gives fisken i periode forud for udsættelse for en infektion, under infektionen, eller efter at fisken er blevet inficeret.
8. Fodersammensætning ifølge krav 5, hvori vægtforholdet af nukleotider til peptidoglykan er mere end 4, mere foretrukket mere end 20, og mere foretrukket mere end 40.
9. Fodersammensætning ifølge ethvert af krav 5-8 som en funktionel fodersammensætning til at hindre eller reducere symptomerne relateret til en infektionssygdom i en fisk.
10. Fodersammensætning ifølge ethvert af krav 5-9 til at øge overlevelse og/eller vækst i fisk udsat for en infektion.
11. Fodersymptomerne ifølge ethvert af krav 5-10, hvor infektionen er forårsaget af bakterier som Piscirikettsia salmonis, Moritella viscosa, Francisella sp, Mouth Rot, streptokokinfektioner, Vibrio infektioner; pancreassygdom, NSAV, gællebetændelse (GI), hjerte- og skeletmuskelinflammation (FISMI), smitsom salmoni-deanæmi (ISA) virus, Saprolegniosis og fiskelusangreb.
12. Fodersammensætning ifølge ethvert af krav 5 til 11, hvori fisken er en laksefisk, fortrinsvis atlanterhavslaks.
13. Fodersammensætning ifølge krav 5 til effektiv restitution påfølgende en infektion og/eller antibiotisk behandling på grund af en infektion og/eller for at reducere risikoen for reinfektion.
14. Sammensætning ifølge ethvert af krav 1-4 til anvendelse ved fodring af fisk, som er modtagelige for en infektion, hvori sammensætningen gives fisken i perioden forud for udsættelse for en infektion, hvori sammensætningen tilføres i en periode på 1-12 uger forud for infektionen.
15. Sammensætning ifølge krav 14, hvori sammensætningen tilføres i en periode på 2-6 uger forud for infektion, og mest foretrukket 4 uger forud for infektion.
16. Sammensætning ifølge krav 14, hvori fisken er en laksefisk, fortrinsvis atlanterhavslaks.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20081977A NO339169B1 (no) | 2008-04-24 | 2008-04-24 | Funksjonelt fiskefôr omfattende peptidoglykan og nukleotider |
| PCT/NO2009/000156 WO2009131467A1 (en) | 2008-04-24 | 2009-04-24 | Functional feed composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2293687T3 true DK2293687T3 (da) | 2016-01-18 |
Family
ID=40829504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09735856.8T DK2293687T3 (da) | 2008-04-24 | 2009-04-24 | Funktionel fodersammensætning |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110152177A1 (da) |
| EP (1) | EP2293687B1 (da) |
| JP (2) | JP2011518559A (da) |
| AU (1) | AU2009238758B2 (da) |
| CA (1) | CA2721746C (da) |
| CL (1) | CL2009000987A1 (da) |
| DK (1) | DK2293687T3 (da) |
| ES (1) | ES2560517T3 (da) |
| NO (2) | NO339169B1 (da) |
| NZ (1) | NZ589483A (da) |
| WO (1) | WO2009131467A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO341929B1 (no) * | 2009-09-14 | 2018-02-19 | Chemoforma Ltd | Fôrsammensetning |
| CA2989391C (en) | 2014-06-24 | 2023-03-14 | John O'halloran | Fish feed compositions containing a neonicotinoid for preventing and treating parasite infections |
| KR101755255B1 (ko) * | 2015-04-30 | 2017-07-07 | 연세대학교 원주산학협력단 | 저대사 유도용 조성물, 저대사 유도방법 및 그 기술을 이용한 어류 운송방법 |
| US11019836B2 (en) * | 2015-08-03 | 2021-06-01 | Savage River, Inc. | Food products comprising cell wall material |
| WO2026008873A1 (en) | 2024-07-04 | 2026-01-08 | Microharvest Gmbh | Feed compositions comprising microbial biomass for fish, crustaceans and/or cephalopods |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5422919B1 (da) * | 1969-02-21 | 1979-08-09 | ||
| JPH03164140A (ja) * | 1989-11-21 | 1991-07-16 | Sanyo Kokusaku Pulp Co Ltd | 養魚用飼料組成物 |
| JPH0655107B2 (ja) * | 1991-03-13 | 1994-07-27 | 全国農業協同組合連合会 | 家畜，家禽，および魚介類用の抗仮性狂犬病ならびに抗病性飼料および飼料用添加物 |
| JP3636207B2 (ja) * | 1991-09-13 | 2005-04-06 | エーザイ株式会社 | 免疫賦活・感染防御剤及びその製造方法 |
| JP2547371B2 (ja) * | 1992-03-03 | 1996-10-23 | 全国農業協同組合連合会 | 甲殻類、魚類用飼料、及び魚類用飼料の給餌方法 |
| JPH06217712A (ja) * | 1993-01-27 | 1994-08-09 | Nippon Nousan Kogyo Kk | 甲殻類用飼料 |
| JP2756907B2 (ja) * | 1993-12-28 | 1998-05-25 | 日本製紙株式会社 | 酵母エキス組成物及びその製造法並びにそれを含有する飼料 |
| JPH10229831A (ja) * | 1997-02-18 | 1998-09-02 | Nippon Nousan Kogyo Kk | 甲殻類の免疫賦活方法及び飼料添加剤 |
| JP3942257B2 (ja) * | 1998-01-06 | 2007-07-11 | 希能 澤口 | 機能性食品 |
| JPH11255664A (ja) * | 1998-03-10 | 1999-09-21 | Ajinomoto Co Inc | 経口投与用免疫増強剤 |
| KR20010071331A (ko) * | 1999-03-26 | 2001-07-28 | 겐이치로 소마 | 갑각류 또는 어류용 사료첨가제 및 사료 |
| WO2001026481A1 (en) * | 1999-10-13 | 2001-04-19 | Ewos Limited | Fish feed with increased nucleotide content |
| JP2001342141A (ja) * | 2000-03-29 | 2001-12-11 | Gotoo Yoshoku Kenkyusho:Kk | 水棲動物・陸棲動物用薬剤及び飼料 |
| JP2001342140A (ja) * | 2000-03-29 | 2001-12-11 | Gotoo Yoshoku Kenkyusho:Kk | 魚類・甲殻類用薬剤及び飼料 |
| JP2001340055A (ja) * | 2000-03-31 | 2001-12-11 | Nippon Paper Industries Co Ltd | 家畜、家禽類給餌方法および給餌用人工乳組成物 |
| JP2002173429A (ja) * | 2000-09-29 | 2002-06-21 | Nippon Paper Industries Co Ltd | 魚類の免疫増強剤及び養魚用飼料 |
| DE60234375D1 (de) * | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| NO315184B1 (no) * | 2001-09-26 | 2003-07-28 | Firmenich & Cie | Anvendelse av en sammensetning basert på fiskemelke for fremstilling av etpreparat som öker immunoglobulinproduksjonen |
| AU2002343020A1 (en) * | 2001-11-16 | 2003-06-10 | Regent Research L.L.P. | A plant extract active as an immunostimulating agent |
| BR0311995A (pt) * | 2002-06-20 | 2005-04-05 | Cytos Biotechnology Ag | Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso |
| JP2004121015A (ja) * | 2002-09-30 | 2004-04-22 | Kohjin Co Ltd | 養殖魚の筋肉負担軽減化方法 |
| WO2007095313A2 (en) * | 2006-02-10 | 2007-08-23 | The Roan Group, Inc. | Microencapsulated nucleotide formulations for aquaculture and land animal feeds |
| EP2687102B8 (en) * | 2006-10-25 | 2018-10-31 | Ewos Innovation AS | Method for improving the colour of fish |
-
2008
- 2008-04-24 NO NO20081977A patent/NO339169B1/no unknown
-
2009
- 2009-04-24 EP EP09735856.8A patent/EP2293687B1/en active Active
- 2009-04-24 JP JP2011506221A patent/JP2011518559A/ja active Pending
- 2009-04-24 WO PCT/NO2009/000156 patent/WO2009131467A1/en not_active Ceased
- 2009-04-24 ES ES09735856.8T patent/ES2560517T3/es active Active
- 2009-04-24 NZ NZ589483A patent/NZ589483A/en unknown
- 2009-04-24 DK DK09735856.8T patent/DK2293687T3/da active
- 2009-04-24 CL CL2009000987A patent/CL2009000987A1/es unknown
- 2009-04-24 AU AU2009238758A patent/AU2009238758B2/en active Active
- 2009-04-24 CA CA2721746A patent/CA2721746C/en active Active
- 2009-04-24 US US12/988,792 patent/US20110152177A1/en not_active Abandoned
-
2010
- 2010-11-03 NO NO20101539A patent/NO20101539L/no not_active Application Discontinuation
-
2014
- 2014-08-22 JP JP2014169708A patent/JP2015027299A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2293687A1 (en) | 2011-03-16 |
| EP2293687B1 (en) | 2015-10-28 |
| AU2009238758B2 (en) | 2014-01-30 |
| CL2009000987A1 (es) | 2010-06-11 |
| CA2721746A1 (en) | 2009-10-29 |
| NO20081977L (no) | 2009-10-26 |
| US20110152177A1 (en) | 2011-06-23 |
| JP2011518559A (ja) | 2011-06-30 |
| AU2009238758A2 (en) | 2012-11-15 |
| NO339169B1 (no) | 2016-11-14 |
| NZ589483A (en) | 2012-07-27 |
| ES2560517T3 (es) | 2016-02-19 |
| CA2721746C (en) | 2015-06-23 |
| AU2009238758A1 (en) | 2009-10-29 |
| JP2015027299A (ja) | 2015-02-12 |
| NO20101539L (no) | 2010-12-21 |
| WO2009131467A1 (en) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hossain et al. | Recent advances of nucleotide nutrition research in aquaculture: a review | |
| Gatlin III | Nutrition and fish health | |
| Banu et al. | Probiotic yeast enhanced growth performance and disease resistance in freshwater catfish gulsa tengra, Mystus cavasius | |
| US20220184159A1 (en) | Method of boosting innate immunity | |
| DK2293687T3 (da) | Funktionel fodersammensætning | |
| Montajami et al. | Effect of symbiotic (Biomin imbo) on growth performance and survival rate of Texas cichlid (Herichthys cyanoguttatus) larvae | |
| US20220338506A1 (en) | Method of increasing the productivity of a non-ruminant animal | |
| Anuta et al. | Effects of dietary supplementation of a commercial prebiotic P revida® on survival, growth, immune responses and gut microbiota of P acific white shrimp, L Itopenaeus vannamei | |
| Arciuch-Rutkowska et al. | Effects of the diet enrichment with β-glucan, sodium salt of butyric acid and vitamins on growth parameters and the profile of the gut microbiome of juvenile African catfish (Clarias gariepinus) | |
| Jaramillo Jr et al. | Comparison of purified and practical diets supplemented with or without β‐glucan and selenium on resistance of hybrid striped bass morone chrysops♀× M. saxatilis♂ to Streptococcus iniae infection | |
| CA2576516C (fr) | Additif alimentaire | |
| Webster et al. | Protein, amino acids, and ingredients | |
| Gatlin et al. | Nucleotides. | |
| JPH05192088A (ja) | 改善された養魚法 | |
| Divya et al. | Effect of enriched Artemia franciscana on production, survival, growth and biochemical composition of the freshwater fish Catla catla (Hamilton, 1922) | |
| Felix et al. | Dietary mannan oligosaccharide enhances growth and survival of juvenile tiger shrimp Penaeus monodon against experimental challenge with Vibrio harveyi and white spot syndrome virus | |
| Ng et al. | Lactic acid enhanced the growth performance and resistance to Vibrio harveyi infection when added in the feeds of the giant freshwater prawn, Macrobrachium rosenbergii. | |
| Ghetas et al. | Effects of glucans and nucleotides on the immunity, health, and growth of fish. A review with special reference to the Egyptian situation | |
| Palíková et al. | Preventive and prophylactic measures in intensive salmonid fish breeding–a review | |
| Li et al. | Strategies of dietary supplementation for health management of hybrid striped bass Morone chrysops x M. saxatilis: a review of research at Texas A&M University | |
| Mohseni et al. | Effect of brewer’s yeast (Saccharomyces cerevisiae) on growth, survival and immune response in Labeo rohita | |
| Khodadadi et al. | Dietary effect of celmanax® on growth factor, intestine histology and yersiniosis resistance in rainbow trout (Oncorhynchus mykiss) | |
| Boloki et al. | The effects of Amax yeast fed to Persian sturgeon (Acipencer persicus) larvae via bioenrichment of Daphnia magna. | |
| Jafaryan et al. | The effects of Amax yeast fed to Persian sturgeon (Acipencer persicus) larvae via bioenrichment of Daphnia magna | |
| Adineh | Aquaculture, Aquarium, Conservation & Legislation International Journal of the Bioflux Society The effects of Amax yeast fed to Persian sturgeon (Acipencer persicus) larvae via bioenrichment of Daphnia magna |